Skip to main content
TipRanks
Go Ultimate75% OFF

Welby Inc. (4438) AI Stock Analysis

0 Followers
JP:4438

Welby Inc.

(TSE/TYO:4438)

Select Model
Rating:46.9Neutral
Price Target:JPY 249.00▼(-1.19% Downside)
Action:reiterated
Date:10/22/26

The overall score is heavily pressured by the company's precarious financial state, marked by deep losses, high leverage, and significant cash burn. While recent price momentum and moving averages offer a positive technical signal, the fundamental lack of profitability and a negative P/E ratio present substantial risks that dominate the outlook.

Positive Factors
Revenue ReboundThe strong 2025 revenue rebound indicates that the company can regain demand after a weak period, supporting renewed scale and operating leverage potential. Although growth has been volatile, a higher revenue base could improve fixed-cost absorption if the recovery is sustained over coming quarters.
Negative Factors
Persistent LossesPersistent operating and net losses show that strong gross profit is not yet translating into a viable earnings model. Continued losses can erode equity, constrain reinvestment, and make future growth dependent on additional financing rather than internally generated profits.

Welby Inc. (4438) vs. iShares MSCI Japan ETF (EWJ)

-20%-10%0%10%20%30%40%50%60%JP:4438-14.86%EWJ+14.66%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 2.14B
Dividend Yield
―
Average Volume (3M)
166.99K
Price to Earnings (P/E)
-4.7
Beta (1Y)
1.27
Revenue Growth
34.13%
EPS Growth
35.54%
Country
Japan
Employees
44
Sector
General
Sector Strength
55
Industry
Medical - Healthcare Information Services

Welby Inc. Business Overview & Revenue Model

Company Description

Established in Tokyo, Japan, in 2011, Welby Inc. specializes in developing digital healthcare solutions aimed at enhancing patients' access to and engagement with medical services. The company's extensive portfolio addresses a wide array of health co...

Welby Inc. Financial Statement Overview

Summary

Financial health is weak. While revenue grew 20% and gross margin is strong at 70.6%, the company is deeply unprofitable with a -71.2% EBIT margin. Cash burn is severe (FCF -¥332.3M) and the balance sheet is highly leveraged with a debt-to-equity ratio of 2.22, indicating significant financial risk.

Income Statement

15Very Negative

Balance Sheet

20Very Negative

Cash Flow

12Very Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue648.58M635.72M528.04M575.00M1.05B1.14B
Gross Profit454.44M448.67M379.92M376.00M755.44M683.91M
EBITDA-404.35M-500.26M-792.75M-499.97M40.29M-127.70M
Net Income-525.32M-539.69M-804.60M-505.00M33.91M-130.68M
Balance Sheet
Total Assets847.17M1.05B1.17B1.21B1.40B1.39B
Cash, Cash Equivalents and Short-Term Investments516.23M711.43M740.43M883.00M830.82M960.72M
Total Debt539.39M605.71M200.00M1.21M8.35M15.49M
Total Liabilities636.94M747.89M328.90M88.00M121.40M134.83M
Stockholders Equity180.92M272.33M810.02M1.09B1.27B1.26B
Cash Flow
Free Cash Flow0-332.29M-776.25M-177.00M-146.86M-115.46M
Operating Cash Flow0-329.49M-603.63M-174.00M-114.11M-95.95M
Investing Cash Flow0272.44M-235.84M-114.39M-7.04M-34.56M
Financing Cash Flow028.05M696.54M341.25M-8.74M-7.14M

Welby Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price252.00

Price Trends

50DMA280.56Negative
100DMA266.06Negative
200DMA286.86Negative

Market Momentum

MACD-6.83Positive
RSI39.77Neutral
STOCH29.36Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4438, the sentiment is Negative. The current price of 252.00 is below the 20-day moving average (MA) of 279.90, below the 50-day MA of 280.56, and below the 200-day MA of 286.86, indicating a bearish trend. The MACD of -6.83 indicates Positive momentum. The RSI at 39.77 is Neutral, neither overbought nor oversold. The STOCH value of 29.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4438.

Welby Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:4438 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4483JP:448372OutperformJPY 241.18B32.85―0.49%20.50%19.27%
JP:9438JP:943871OutperformJPY 27.02B12.50―3.99%3.99%-34.91%
JP:5592JP:559270NeutralJPY 24.09B8.38―1.81%18.66%-10.20%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4480JP:448054NeutralJPY 60.40B34.6611.30%―21.01%10.15%
JP:4438JP:443847NeutralJPY 2.15B-4.66――34.13%35.54%

* General Sector Average

Performance Comparison

-40%-20%0%20%40%JP:4438JP:4480JP:4483JP:5592JP:9438Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4438 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4438Welby Inc.252.00-48.00-16.00%
JP:4480Medley, Inc.1899.00-728.00-27.71%
JP:4483JMDC Inc.3685.00-400.13-9.79%
JP:5592Kusurinomadoguchi, Inc.2102.00-546.98-20.65%
JP:9438MTI Ltd.501.00-228.45-31.32%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 22, 2026